Delhi, [India] July 31, 2026: In a heartening story of hope, timely decision-making and the promise of stem cell preservation, a young child diagnosed with thalassaemia major has moved towards a healthier future after undergoing a successful stem cell transplant using preserved newborn stem cells from his younger sibling.
Mantra, the family’s elder son, was diagnosed with thalassaemia major at just two-and-a-half months of age. Since then, his life depended on regular blood transfusions, a routine that became both emotionally and physically challenging for the family. Over time, repeated transfusions also resulted in iron overload, making iron chelation therapy an essential part of his ongoing treatment.
Like many parents facing such a difficult diagnosis, Mantra’s family continued searching for a long-term solution. After consulting medical specialists and speaking with other families, they learnt that a stem cell transplant could offer a potentially curative treatment option for eligible patients with thalassaemia. However, a successful transplant requires a suitably matched donor.
When the family’s younger child was born, the parents made the important decision to preserve his newborn stem cells with Cryoviva Life Sciences, hoping they might one day support Mantra’s treatment journey. When the appropriate time came, Mantra underwent a stem cell transplant using the preserved stem cells stored with Cryoviva, along with freshly collected stem cells from his younger sibling.
Speaking about the case, a Dr. Aditi Kundu, Medical Director, Cryoviva Life Sciences said:
“Stories like Mantra’s reinforce our belief in the long-term value of newborn stem cell preservation. For families affected by serious conditions such as thalassaemia, preserved stem cells can become an important medical resource when clinically appropriate. We are grateful to have played a supportive role in this family’s journey and remain committed to helping parents make informed decisions for their children’s future.”
Today, Mantra no longer requires regular blood transfusions or iron chelation therapy, marking a life-changing milestone for him and his family. His journey serves as a powerful reminder of how awareness, timely medical guidance and stem cell preservation can together create new possibilities for families living with thalassaemia.
The family hopes their experience will encourage other parents, particularly those with a child affected by thalassaemia, to explore newborn stem cell preservation and discuss suitable treatment options with qualified medical professionals.
